aTYR PHARMA INC (LIFE) Net Income (Loss) Attributable to Parent USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
aTYR PHARMA INC quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2024.
  • aTYR PHARMA INC Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$15.5 M, a 29.6% decline year-over-year.
  • aTYR PHARMA INC Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$53.9 M, a 19.5% decline year-over-year.
  • aTYR PHARMA INC annual Net Income (Loss) Attributable to Parent for 2023 was -$50.4 M, a 11.1% decline from 2022.
  • aTYR PHARMA INC annual Net Income (Loss) Attributable to Parent for 2022 was -$45.3 M, a 34.3% decline from 2021.
  • aTYR PHARMA INC annual Net Income (Loss) Attributable to Parent for 2021 was -$33.8 M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$53.9 M -$15.5 M -$3.54 M -29.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$50.4 M -$14.8 M -$7.24 M -96.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$43.2 M -$11.3 M +$1.9 M +14.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$45.1 M -$12.3 M +$82 K +0.66% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$45.1 M -$12 M +$202 K +1.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$45.3 M -$7.52 M +$1.04 M +12.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$46.4 M -$13.2 M -$5.58 M -72.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$40.8 M -$12.4 M -$2.03 M -19.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$38.8 M -$12.2 M -$5 M -69.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$33.8 M -$8.56 M -$3.63 M -73.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$30.1 M -$7.67 M -$1.07 M -16.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$29.1 M -$10.4 M -$3.95 M -61.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$25.1 M -$7.15 M -$8.9 M -508% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$16.2 M -$4.93 M +$1.04 M +17.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 -$17.3 M -$6.6 M -$954 K -16.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$16.3 M -$6.45 M -$598 K -10.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$15.7 M $1.75 M +$7.89 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$23.6 M -$5.97 M +$349 K +5.52% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-26
Q3 2019 -$24 M -$5.65 M +$1.47 M +20.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$25.4 M -$5.85 M +$4.56 M +43.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$30 M -$6.14 M +$4.53 M +42.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$34.5 M -$6.32 M +$5.15 M +44.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$39.7 M -$7.11 M +$4.08 M +36.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-26
Q2 2018 -$43.7 M -$10.4 M +$1.73 M +14.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-26
Q1 2018 -$45.5 M -$10.7 M +$2.74 M +20.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-26
Q4 2017 -$48.2 M -$11.5 M +$1.09 M +8.69% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 -$49.3 M -$11.2 M +$2.63 M +19% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-26
Q2 2017 -$51.9 M -$12.1 M +$3.25 M +21.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-26
Q1 2017 -$55.2 M -$13.4 M +$2.68 M +16.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-26
Q4 2016 -$57.9 M -$12.6 M +$3.93 M +23.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$61.8 M -$13.8 M -$2.49 M -22% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-20
Q2 2016 -$59.3 M -$15.4 M -$4.3 M -38.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-20
Q1 2016 -$55 M -$16.1 M -$7.02 M -77.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-20
Q4 2015 -$48 M -$16.5 M -$10.5 M -173% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$37.5 M -$11.3 M -$4.7 M -70.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$32.8 M -$11.1 M -$5.49 M -98.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$27.3 M -$9.07 M -$2.98 M -48.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$24.4 M -$6.04 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$6.63 M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$5.59 M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$6.09 M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.